ReviewThe Journal of pharmacology and experimental therapeutics2025

Alzheimer disease: Amyloid peptide controversies and challenges of anti-Aβ immunotherapy.

Najlaa Hamed Almohmadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.